{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:00:09Z","timestamp":1790834409680,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000238","name":"Brain Tumour Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012634","name":"Novocure UK Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017655","name":"Incyte","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004734","name":"Jewish General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004734","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ijrobp.2025.08.066","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:30:47Z","timestamp":1759210247000},"page":"278-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Tumor Treating Fields Therapy After Stereotactic Radiosurgery for Brain Metastases From Non-Small Cell Lung Cancer: Final Results of the Phase 3 METIS Study"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4812-5713","authenticated-orcid":false,"given":"Minesh P.","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinai","family":"Gondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manmeet Singh","family":"Ahluwalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Roberge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence Tai Weng","family":"Sio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Trifiletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Muanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Misir","family":"Krpan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengfei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naren R.","family":"Ramakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Fiveash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Metellus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiachien Jake","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian F.","family":"Freyschlag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor","family":"Cs\u0151szi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Salmaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa","family":"Taliansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Harat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.08.066_bib0001","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/cncr.10541","article-title":"Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma","volume":"94","author":"Schouten","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0002","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1038\/s41467-023-40793-x","article-title":"Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis","volume":"14","author":"Skakodub","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0003","article-title":"Quality of life and role of palliative and supportive care for patients with brain metastases and caregivers: A review","volume":"13","author":"Wu","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0004","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/CCO.0000000000000581","article-title":"Treatment of cognitive deficits in brain tumour patients: Current status and future directions","volume":"31","author":"Coomans","year":"2019","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0005","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3171\/2014.12.JNS141111","article-title":"Gamma knife radiosurgery for the management of cerebral metastases from non-small cell lung cancer","volume":"122","author":"Bowden","year":"2015","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0006","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1227\/neu.0000000000002372","article-title":"Extended survival in patients with non-small-cell lung cancer-associated brain metastases in the modern era","volume":"93","author":"Berger","year":"2023","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0007","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0008","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ijrobp.2019.03.052","article-title":"Initial SRS for patients with 5 to 15 brain metastases: Results of a multi-institutional experience","volume":"104","author":"Hughes","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0009","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.adro.2019.11.001","article-title":"A cohort study of stereotactic radiosurgery results for patients with 5 to 15 versus 2 to 4 brain metastatic tumors","volume":"5","author":"Yamamoto","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0010","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1016\/j.wneu.2020.10.124","article-title":"Stereotactic radiosurgery results for patients with 5-10 versus 11-20 brain metastases: A retrospective cohort study combining 2 databases totaling 2319 patients","volume":"146","author":"Yamamoto","year":"2021","journal-title":"World Neurosurg"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0011","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1200\/JCO.2010.33.3294","article-title":"The dandelion effect: Treat the whole lawn or weed selectively?","volume":"29","author":"Mehta","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0012","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3171\/2016.5.JNS153051","article-title":"Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery","volume":"127","author":"McKay","year":"2017","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0013","first-page":"1","article-title":"Repeat stereotactic radiosurgery for locally recurrent brain metastases previously treated with stereotactic radiosurgery: A systematic review and meta-analysis of efficacy and safety","volume":"8","author":"Singh","year":"2022","journal-title":"J Radiosurg SBRT"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0014","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.3390\/cancers14215293","article-title":"Re-whole brain radiotherapy may be one of the treatment choices for symptomatic brain metastases patients","volume":"14","author":"Ono","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0015","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1158\/0008-5472.CAN-04-0083","article-title":"Disruption of cancer cell replication by alternating electric fields","volume":"64","author":"Kirson","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0016","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1158\/1078-0432.CCR-17-1117","article-title":"Tumor-treating fields: A fourth modality in cancer treatment","volume":"24","author":"Mun","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0017","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.3390\/cancers12103016","article-title":"Tumor treating fields (TTFields) hinder cancer cell motility through regulation of microtubule and acting dynamics","volume":"12","author":"Voloshin","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0018","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41416-020-01136-5","article-title":"Tumour treating fields therapy for glioblastoma: Current advances and future directions","volume":"124","author":"Rominiyi","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0019","unstructured":"Novocure. Optune Lua\u00ae for non-small cell lung cancer (NSCLC) \u2013 Patient information and operation manual. Available at: https:\/\/assets.novocure.biz\/optunelua\/2024-10\/Optune%20Lua%20NSCLC%20ITE%20PIOM_v%2008.pdf. Accessed August 25, 2025."},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0020","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S1470-2045(23)00344-3","article-title":"Tumor treating fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): A randomised, open-label, pivotal phase 3 study","volume":"24","author":"Leal","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0021","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: A randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-023-04348-w","article-title":"Association of tumor treating fields (TTFields) therapy with survival in newly diagnosed glioblastoma: A systematic review and meta-analysis","volume":"164","author":"Ballo","year":"2023","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0023","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/j.ejca.2012.04.011","article-title":"NovoTTF-100A versus physician\u2019s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality","volume":"48","author":"Stupp","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0024","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1200\/JCO-25-00746","article-title":"Tumor treating fields with gemcitabine and nab-paclitaxel for locally advanced pancreatic adenocarcinoma: Randomized, open-label, pivotal phase III PANOVA-3 study","volume":"43","author":"Babiker","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0025","unstructured":"Novocure. Optune GioTM. Instructions for use. 2023. Available at: https:\/\/assets.novocure.biz\/patient\/QSD-QR-703%20US%28EN%29%20Commercial%20Optune%20Gio%20INE_IFU%20Rev04.pdf. Accessed August 25, 2025."},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0026","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s12957-015-0722-3","article-title":"NovoTTF\u2122-100A System (tumor treating fields) transducer array layout planning for glioblastoma: A NovoTAL\u2122 system user study","volume":"13","author":"Chaudhry","year":"2015","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0027","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","article-title":"Response assessment criteria for brain metastases: Proposal from the RANO group","volume":"16","author":"Lin","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0028","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised recist guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0029","unstructured":"National Cancer Institute, Common Terminology Criteria for Adverse Events (CTCAE). Availabel at: v4.03 https:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. Accessed August 25, 2025."},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0030","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1177\/0272989X15587497","article-title":"Mapping functions in health-related quality of life: Mapping from two cancer-specific health-related quality-of-life instruments to EQ-5D-3L","volume":"35","author":"Young","year":"2015","journal-title":"Med Decis Making"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0031","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejca.2023.04.027","article-title":"Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types","volume":"188","author":"Musoro","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0032","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/(SICI)1097-0258(19980315\/15)17:5\/7<603::AID-SIM807>3.0.CO;2-D","article-title":"Completion rates in health-related quality-of-life assessment: Approach of the National Cancer Institute of Canada Clinical Trials Group","volume":"17","author":"Osoba","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0033","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","article-title":"Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: A randomized controlled trial","volume":"295","author":"Aoyama","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0034","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","article-title":"Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: Results of the EORTC 22952-26001 study","volume":"29","author":"Kocher","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: A randomized clinical trial","volume":"316","author":"Brown","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0036","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.10117","article-title":"Intracranial and extracranial progression and their correlation with overall survival after stereotactic radiosurgery in a multi-institutional cohort with brain metastases","volume":"6","author":"Carpenter","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0037","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00066-008-1830-6","article-title":"Acute neurocognitive impairment during cranial radiation therapy in patients with intracranial tumors","volume":"184","author":"Welzel","year":"2008","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0038","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.2006.09.2536","article-title":"Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function","volume":"25","author":"Li","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0039","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214073","article-title":"Tumor treating fields (TTFields) concomitant with immune checkpoint inhibitors are therapeutically effective in non-small cell lung cancer (NSCLC) in vivo model","volume":"23","author":"Barsheshet","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0040","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00262-020-02534-7","article-title":"Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy","volume":"69","author":"Voloshin","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0041","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149258","article-title":"Tumor treating fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma","volume":"132","author":"Chen","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2025.100708","article-title":"Efficacy and safety of adjuvant TTFields plus pembrolizumab and temozolomide in newly diagnosed glioblastoma: A phase 2 study","volume":"6","author":"Chen","year":"2025","journal-title":"Med"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0043","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fonc.2018.00154","article-title":"Stereotactic radiosurgery in the management of patients with brain metastases of non-small cell lung cancer: Indications, decision tools and future directions","volume":"8","author":"Hartgerink","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2025.08.066_bib0044","doi-asserted-by":"crossref","first-page":"975","DOI":"10.21037\/tlcr-24-979","article-title":"Recent advancements in lung cancer research: A narrative review","volume":"14","author":"Tang","year":"2025","journal-title":"Transl Lung Cancer Res"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625062170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625062170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:54:33Z","timestamp":1773158073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301625062170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0360301625062170"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.08.066","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor Treating Fields Therapy After Stereotactic Radiosurgery for Brain Metastases From Non-Small Cell Lung Cancer: Final Results of the Phase 3 METIS Study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.08.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}